Listed

Contineum Therapeutics, Inc.

CTNMNasdaqCIK 1855175HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$0, Q4 FY2024
Operating income−$17.4m, Q2 FY2026
Net income−$15.2m, Q2 FY2026
Line itemUnitperiod not labelled2023-09-30period not labelled2023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m0.0Revenue, period not labelled, three months to 2023-09-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-06, accession 0001437749-24-033616.Report this figure0.0Revenue, period not labelled, three months to 2023-12-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-06, accession 0001437749-25-006458. Derived: 12-month figure less the 9-month figure.Report this figurenot reported0.0Revenue, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-08-14, accession 0001437749-24-026680.Report this figure0.0Revenue, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-06, accession 0001437749-24-033616.Report this figure0.0Revenue, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-06, accession 0001437749-25-006458. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reported
Research and development$m6.5Research and development, period not labelled, three months to 2023-09-30$6.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-06, accession 0001437749-24-033616.Report this figure8.0Research and development, period not labelled, three months to 2023-12-31$8.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-06, accession 0001437749-25-006458. Derived: 12-month figure less the 9-month figure.Report this figure7.8Research and development, Q1 FY2024, three months to 2024-03-31$7.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-14, accession 0001437749-25-016835.Report this figure7.9Research and development, Q2 FY2024, three months to 2024-06-30$7.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-05, accession 0001437749-25-024852.Report this figure9.7Research and development, Q3 FY2024, three months to 2024-09-30$9.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-10-30, accession 0001437749-25-032427.Report this figure13.0Research and development, Q4 FY2024, three months to 2024-12-31$13.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-05, accession 0001628280-26-015165. Derived: 12-month figure less the 9-month figure.Report this figure13.7Research and development, Q1 FY2025, three months to 2025-03-31$13.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-05, accession 0001628280-26-030614.Report this figure14.1Research and development, Q2 FY2025, three months to 2025-06-30$14.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-07-30, accession 0001628280-26-051054.Report this figure11.0Research and development, Q3 FY2025, three months to 2025-09-30$11.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-10-30, accession 0001437749-25-032427.Report this figure12.8Research and development, Q4 FY2025, three months to 2025-12-31$12.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-05, accession 0001628280-26-015165. Derived: 12-month figure less the 9-month figure.Report this figure11.6Research and development, Q1 FY2026, three months to 2026-03-31$11.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-05, accession 0001628280-26-030614.Report this figure12.7Research and development, Q2 FY2026, three months to 2026-06-30$12.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-07-30, accession 0001628280-26-051054.Report this figure
Operating income$m(8.1)Operating income, period not labelled, three months to 2023-09-30−$8.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-06, accession 0001437749-24-033616.Report this figure(9.7)Operating income, period not labelled, three months to 2023-12-31−$9.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-06, accession 0001437749-25-006458. Derived: 12-month figure less the 9-month figure.Report this figure(9.9)Operating income, Q1 FY2024, three months to 2024-03-31−$9.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-14, accession 0001437749-25-016835.Report this figure(10.9)Operating income, Q2 FY2024, three months to 2024-06-30−$10.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-05, accession 0001437749-25-024852.Report this figure(13.0)Operating income, Q3 FY2024, three months to 2024-09-30−$13.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-30, accession 0001437749-25-032427.Report this figure(17.0)Operating income, Q4 FY2024, three months to 2024-12-31−$17.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-05, accession 0001628280-26-015165. Derived: 12-month figure less the 9-month figure.Report this figure(18.1)Operating income, Q1 FY2025, three months to 2025-03-31−$18.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-05, accession 0001628280-26-030614.Report this figure(17.9)Operating income, Q2 FY2025, three months to 2025-06-30−$17.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-30, accession 0001628280-26-051054.Report this figure(14.9)Operating income, Q3 FY2025, three months to 2025-09-30−$14.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-30, accession 0001437749-25-032427.Report this figure(17.1)Operating income, Q4 FY2025, three months to 2025-12-31−$17.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-05, accession 0001628280-26-015165. Derived: 12-month figure less the 9-month figure.Report this figure(16.9)Operating income, Q1 FY2026, three months to 2026-03-31−$16.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-05, accession 0001628280-26-030614.Report this figure(17.4)Operating income, Q2 FY2026, three months to 2026-06-30−$17.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-30, accession 0001628280-26-051054.Report this figure
Interest expense$m0.0Interest expense, period not labelled, three months to 2023-09-30$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2024-11-06, accession 0001437749-24-033616.Report this figure0.0Interest expense, period not labelled, three months to 2023-12-31$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2025-03-06, accession 0001437749-25-006458. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2024-05-16, accession 0001437749-24-017320.Report this figure0.0Interest expense, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2024-08-14, accession 0001437749-24-026680.Report this figure0.0Interest expense, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2024-11-06, accession 0001437749-24-033616.Report this figure0.0Interest expense, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2025-03-06, accession 0001437749-25-006458. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reported
Income tax$m(0.1)Income tax, period not labelled, three months to 2023-09-30−$118.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-06, accession 0001437749-24-033616.Report this figure(0.2)Income tax, period not labelled, three months to 2023-12-31−$161.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-06, accession 0001437749-25-006458. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-05-16, accession 0001437749-24-017320.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-08-14, accession 0001437749-24-026680.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-06, accession 0001437749-24-033616.Report this figure0.0Income tax, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-05, accession 0001628280-26-015165. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reported
Net income$m(6.3)Net income, period not labelled, three months to 2023-09-30−$6.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-06, accession 0001437749-24-033616.Report this figure(7.8)Net income, period not labelled, three months to 2023-12-31−$7.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-06, accession 0001437749-25-006458. Derived: 12-month figure less the 9-month figure.Report this figure(8.4)Net income, Q1 FY2024, three months to 2024-03-31−$8.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-30, accession 0001437749-25-032427.Report this figure(9.0)Net income, Q2 FY2024, three months to 2024-06-30−$9.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-30, accession 0001437749-25-032427.Report this figure(10.3)Net income, Q3 FY2024, three months to 2024-09-30−$10.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-30, accession 0001437749-25-032427.Report this figure(14.6)Net income, Q4 FY2024, three months to 2024-12-31−$14.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-05, accession 0001628280-26-015165. Derived: 12-month figure less the 9-month figure.Report this figure(16.0)Net income, Q1 FY2025, three months to 2025-03-31−$16.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-30, accession 0001628280-26-051054.Report this figure(16.0)Net income, Q2 FY2025, three months to 2025-06-30−$16.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-30, accession 0001628280-26-051054.Report this figure(12.8)Net income, Q3 FY2025, three months to 2025-09-30−$12.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-30, accession 0001437749-25-032427.Report this figure(15.2)Net income, Q4 FY2025, three months to 2025-12-31−$15.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-05, accession 0001628280-26-015165. Derived: 12-month figure less the 9-month figure.Report this figure(14.5)Net income, Q1 FY2026, three months to 2026-03-31−$14.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-30, accession 0001628280-26-051054.Report this figure(15.2)Net income, Q2 FY2026, three months to 2026-06-30−$15.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-30, accession 0001628280-26-051054.Report this figure
Diluted EPS$ per share(2.69)Diluted EPS, period not labelled, three months to 2023-09-30−$2.69 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-06, accession 0001437749-24-033616.Report this figurenot reportednot reported(0.39)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.39 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-08-14, accession 0001437749-24-026680.Report this figure(0.40)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.40 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-06, accession 0001437749-24-033616.Report this figurenot reported(0.62)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.62 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-05, accession 0001628280-26-030614.Report this figure(0.62)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.62 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-30, accession 0001628280-26-051054.Report this figurenot reportednot reported(0.39)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.39 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-05, accession 0001628280-26-030614.Report this figure(0.40)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.40 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-30, accession 0001628280-26-051054.Report this figure
Basic EPS$ per share(2.69)Basic EPS, period not labelled, three months to 2023-09-30−$2.69 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-06, accession 0001437749-24-033616.Report this figurenot reported(3.55)Basic EPS, Q1 FY2024, three months to 2024-03-31−$3.55 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-14, accession 0001437749-25-016835.Report this figure(0.39)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.39 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-05, accession 0001437749-25-024852.Report this figure(0.40)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.40 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-10-30, accession 0001437749-25-032427.Report this figurenot reported(0.62)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.62 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-05, accession 0001628280-26-030614.Report this figure(0.62)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.62 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-07-30, accession 0001628280-26-051054.Report this figure(0.45)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.45 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-10-30, accession 0001437749-25-032427.Report this figurenot reported(0.39)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.39 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-05, accession 0001628280-26-030614.Report this figure(0.40)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.40 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-07-30, accession 0001628280-26-051054.Report this figure

Balance sheet

Cash and equivalents$14.7m, Q2 FY2026
Shareholders' equity$239.7m, Q2 FY2026
Line itemUnitperiod not labelled2023-09-30period not labelled2023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$mnot reported15.5Cash and equivalents, period not labelled, at 2023-12-31$15.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-06, accession 0001437749-25-006458.Report this figure16.3Cash and equivalents, Q1 FY2024, at 2024-03-31$16.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-16, accession 0001437749-24-017320.Report this figure77.2Cash and equivalents, Q2 FY2024, at 2024-06-30$77.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-14, accession 0001437749-24-026680.Report this figure40.9Cash and equivalents, Q3 FY2024, at 2024-09-30$40.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-06, accession 0001437749-24-033616.Report this figure21.9Cash and equivalents, FY2024, at 2024-12-31$21.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-05, accession 0001628280-26-015165.Report this figure22.5Cash and equivalents, Q1 FY2025, at 2025-03-31$22.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-14, accession 0001437749-25-016835.Report this figure20.8Cash and equivalents, Q2 FY2025, at 2025-06-30$20.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-05, accession 0001437749-25-024852.Report this figure42.6Cash and equivalents, Q3 FY2025, at 2025-09-30$42.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-10-30, accession 0001437749-25-032427.Report this figure75.6Cash and equivalents, FY2025, at 2025-12-31$75.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-30, accession 0001628280-26-051054.Report this figure20.2Cash and equivalents, Q1 FY2026, at 2026-03-31$20.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-05, accession 0001628280-26-030614.Report this figure14.7Cash and equivalents, Q2 FY2026, at 2026-06-30$14.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-30, accession 0001628280-26-051054.Report this figure
Current assets$mnot reported128Current assets, period not labelled, at 2023-12-31$127.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-06, accession 0001437749-25-006458.Report this figure120Current assets, Q1 FY2024, at 2024-03-31$119.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-16, accession 0001437749-24-017320.Report this figure220Current assets, Q2 FY2024, at 2024-06-30$220.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-14, accession 0001437749-24-026680.Report this figure215Current assets, Q3 FY2024, at 2024-09-30$215.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-06, accession 0001437749-24-033616.Report this figure206Current assets, FY2024, at 2024-12-31$206.4m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-05, accession 0001628280-26-015165.Report this figure192Current assets, Q1 FY2025, at 2025-03-31$192.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-14, accession 0001437749-25-016835.Report this figure177Current assets, Q2 FY2025, at 2025-06-30$176.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-05, accession 0001437749-25-024852.Report this figure185Current assets, Q3 FY2025, at 2025-09-30$184.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-10-30, accession 0001437749-25-032427.Report this figure268Current assets, FY2025, at 2025-12-31$267.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-07-30, accession 0001628280-26-051054.Report this figure253Current assets, Q1 FY2026, at 2026-03-31$253.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-05, accession 0001628280-26-030614.Report this figure243Current assets, Q2 FY2026, at 2026-06-30$242.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-07-30, accession 0001628280-26-051054.Report this figure
Total assets$mnot reported130Total assets, period not labelled, at 2023-12-31$130.4m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-06, accession 0001437749-25-006458.Report this figure124Total assets, Q1 FY2024, at 2024-03-31$123.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-16, accession 0001437749-24-017320.Report this figure221Total assets, Q2 FY2024, at 2024-06-30$221.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-14, accession 0001437749-24-026680.Report this figure216Total assets, Q3 FY2024, at 2024-09-30$216.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-06, accession 0001437749-24-033616.Report this figure213Total assets, FY2024, at 2024-12-31$212.8m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-05, accession 0001628280-26-015165.Report this figure198Total assets, Q1 FY2025, at 2025-03-31$198.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-14, accession 0001437749-25-016835.Report this figure183Total assets, Q2 FY2025, at 2025-06-30$182.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-05, accession 0001437749-25-024852.Report this figure191Total assets, Q3 FY2025, at 2025-09-30$190.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-10-30, accession 0001437749-25-032427.Report this figure277Total assets, FY2025, at 2025-12-31$276.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-07-30, accession 0001628280-26-051054.Report this figure261Total assets, Q1 FY2026, at 2026-03-31$261.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-05, accession 0001628280-26-030614.Report this figure250Total assets, Q2 FY2026, at 2026-06-30$250.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-07-30, accession 0001628280-26-051054.Report this figure
Current liabilities$mnot reported5.5Current liabilities, period not labelled, at 2023-12-31$5.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-06, accession 0001437749-25-006458.Report this figure6.2Current liabilities, Q1 FY2024, at 2024-03-31$6.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-16, accession 0001437749-24-017320.Report this figure3.7Current liabilities, Q2 FY2024, at 2024-06-30$3.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-14, accession 0001437749-24-026680.Report this figure5.8Current liabilities, Q3 FY2024, at 2024-09-30$5.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-06, accession 0001437749-24-033616.Report this figure10.0Current liabilities, FY2024, at 2024-12-31$10.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-05, accession 0001628280-26-015165.Report this figure8.9Current liabilities, Q1 FY2025, at 2025-03-31$8.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-14, accession 0001437749-25-016835.Report this figure7.2Current liabilities, Q2 FY2025, at 2025-06-30$7.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-05, accession 0001437749-25-024852.Report this figure6.4Current liabilities, Q3 FY2025, at 2025-09-30$6.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-10-30, accession 0001437749-25-032427.Report this figure9.7Current liabilities, FY2025, at 2025-12-31$9.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-07-30, accession 0001628280-26-051054.Report this figure6.7Current liabilities, Q1 FY2026, at 2026-03-31$6.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-05, accession 0001628280-26-030614.Report this figure6.5Current liabilities, Q2 FY2026, at 2026-06-30$6.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-07-30, accession 0001628280-26-051054.Report this figure
Total liabilities$mnot reported5.7Total liabilities, period not labelled, at 2023-12-31$5.7m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-06, accession 0001437749-25-006458.Report this figure6.6Total liabilities, Q1 FY2024, at 2024-03-31$6.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-16, accession 0001437749-24-017320.Report this figure3.9Total liabilities, Q2 FY2024, at 2024-06-30$3.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-14, accession 0001437749-24-026680.Report this figure5.8Total liabilities, Q3 FY2024, at 2024-09-30$5.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-06, accession 0001437749-24-033616.Report this figure14.8Total liabilities, FY2024, at 2024-12-31$14.8m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-05, accession 0001628280-26-015165.Report this figure13.5Total liabilities, Q1 FY2025, at 2025-03-31$13.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-14, accession 0001437749-25-016835.Report this figure11.5Total liabilities, Q2 FY2025, at 2025-06-30$11.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-05, accession 0001437749-25-024852.Report this figure10.4Total liabilities, Q3 FY2025, at 2025-09-30$10.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-10-30, accession 0001437749-25-032427.Report this figure15.7Total liabilities, FY2025, at 2025-12-31$15.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-07-30, accession 0001628280-26-051054.Report this figure11.3Total liabilities, Q1 FY2026, at 2026-03-31$11.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-05, accession 0001628280-26-030614.Report this figure10.7Total liabilities, Q2 FY2026, at 2026-06-30$10.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-07-30, accession 0001628280-26-051054.Report this figure
Shareholders' equity$m(61.1)Shareholders' equity, period not labelled, at 2023-09-30−$61.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-06, accession 0001437749-24-033616.Report this figure(67.9)Shareholders' equity, period not labelled, at 2023-12-31−$67.9m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-05, accession 0001628280-26-015165.Report this figure(75.6)Shareholders' equity, Q1 FY2024, at 2024-03-31−$75.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-30, accession 0001437749-25-032427.Report this figure218Shareholders' equity, Q2 FY2024, at 2024-06-30$217.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-30, accession 0001437749-25-032427.Report this figure210Shareholders' equity, Q3 FY2024, at 2024-09-30$210.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-30, accession 0001437749-25-032427.Report this figure198Shareholders' equity, FY2024, at 2024-12-31$198.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-30, accession 0001628280-26-051054.Report this figure185Shareholders' equity, Q1 FY2025, at 2025-03-31$184.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-30, accession 0001628280-26-051054.Report this figure171Shareholders' equity, Q2 FY2025, at 2025-06-30$171.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-30, accession 0001628280-26-051054.Report this figure180Shareholders' equity, Q3 FY2025, at 2025-09-30$180.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-30, accession 0001437749-25-032427.Report this figure261Shareholders' equity, FY2025, at 2025-12-31$261.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-30, accession 0001628280-26-051054.Report this figure250Shareholders' equity, Q1 FY2026, at 2026-03-31$250.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-30, accession 0001628280-26-051054.Report this figure240Shareholders' equity, Q2 FY2026, at 2026-06-30$239.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-30, accession 0001628280-26-051054.Report this figure

Cash flow

Operating cash flow−$11.5m, Q2 FY2026
Capital expenditure$6.0k, Q2 FY2026
Line itemUnitperiod not labelled2023-09-30period not labelled2023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(5.4)Operating cash flow, period not labelled, three months to 2023-09-30−$5.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-06, accession 0001437749-24-033616. Derived: 9-month figure less the 6-month figure.Report this figure(10.7)Operating cash flow, period not labelled, three months to 2023-12-31−$10.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-06, accession 0001437749-25-006458. Derived: 12-month figure less the 9-month figure.Report this figure(8.0)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$8.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-14, accession 0001437749-25-016835.Report this figure(8.5)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$8.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-05, accession 0001437749-25-024852. Derived: 6-month figure less the 3-month figure.Report this figure(6.2)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$6.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-30, accession 0001437749-25-032427. Derived: 9-month figure less the 6-month figure.Report this figure(10.2)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$10.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-05, accession 0001628280-26-015165. Derived: 12-month figure less the 9-month figure.Report this figure(14.4)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$14.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-05, accession 0001628280-26-030614.Report this figure(15.7)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$15.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-30, accession 0001628280-26-051054. Derived: 6-month figure less the 3-month figure.Report this figure(12.2)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$12.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-30, accession 0001437749-25-032427. Derived: 9-month figure less the 6-month figure.Report this figure(13.0)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$13.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-05, accession 0001628280-26-015165. Derived: 12-month figure less the 9-month figure.Report this figure(16.3)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$16.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-05, accession 0001628280-26-030614.Report this figure(11.5)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$11.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-30, accession 0001628280-26-051054. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.0Capital expenditure, period not labelled, three months to 2023-09-30$22.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-06, accession 0001437749-24-033616. Derived: 9-month figure less the 6-month figure.Report this figure0.3Capital expenditure, period not labelled, three months to 2023-12-31$309.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-06, accession 0001437749-25-006458. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2024, three months to 2024-03-31$147.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-14, accession 0001437749-25-016835.Report this figure0.1Capital expenditure, Q2 FY2024, three months to 2024-06-30$119.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-05, accession 0001437749-25-024852. Derived: 6-month figure less the 3-month figure.Report this figure0.1Capital expenditure, Q3 FY2024, three months to 2024-09-30$82.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-30, accession 0001437749-25-032427. Derived: 9-month figure less the 6-month figure.Report this figure0.2Capital expenditure, Q4 FY2024, three months to 2024-12-31$166.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-05, accession 0001628280-26-015165. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$47.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-05, accession 0001628280-26-030614.Report this figure0.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$44.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-30, accession 0001628280-26-051054. Derived: 6-month figure less the 3-month figure.Report this figure0.1Capital expenditure, Q3 FY2025, three months to 2025-09-30$98.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-30, accession 0001437749-25-032427. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$42.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-05, accession 0001628280-26-015165. Derived: 12-month figure less the 9-month figure.Report this figure0.3Capital expenditure, Q1 FY2026, three months to 2026-03-31$312.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-05, accession 0001628280-26-030614.Report this figure0.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$6.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-30, accession 0001628280-26-051054. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)37.47m, Q2 FY2026
Line itemUnitperiod not labelled2023-03-31period not labelled2023-06-30period not labelled2023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares2.3Diluted shares (weighted), period not labelled, three months to 2023-03-312,277,555 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-16, accession 0001437749-24-017320.Report this figure3.5Diluted shares (weighted), period not labelled, three months to 2023-06-303,511,757 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-14, accession 0001437749-24-026680.Report this figure2.3Diluted shares (weighted), period not labelled, three months to 2023-09-302,324,588 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-06, accession 0001437749-24-033616.Report this figure2.4Diluted shares (weighted), Q1 FY2024, three months to 2024-03-312,369,067 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-16, accession 0001437749-24-017320.Report this figure23.4Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3023,355,588 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-14, accession 0001437749-24-026680.Report this figure25.7Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3025,730,014 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-06, accession 0001437749-24-033616.Report this figure25.9Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3125,868,935 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-05, accession 0001628280-26-030614.Report this figure25.9Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3025,895,996 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-07-30, accession 0001628280-26-051054.Report this figure37.3Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3137,339,026 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-05, accession 0001628280-26-030614.Report this figure37.5Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3037,467,840 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-07-30, accession 0001628280-26-051054.Report this figure

Shares outstanding: 23.10mShares outstanding, period not labelled, at 2025-10-2723,099,173 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2025-10-30, accession 0001437749-25-032427.Report this figure at Oct 27, 2025, from the cover of the 10-Q filed Oct 30, 2025.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. Listed shows no prices and gives no investment advice.